TOXICITY MANAGEMENT, SUPPORTIVE MEDICINES AND GENERAL GUIDELINES

Toxicity Management, Supportive Medicines and General Guidelines

All protocols and documents on this website are for the use of St Luke’s Cancer Alliance staff only.
For those who do not work within St Luke’s Cancer Alliance:
Use of this site and any information on it is at your own risk. We do not accept responsibility for reliance on any information that may be set out on the website. You assume full responsibility for the use of the information.

General Guidelines

Cockcroft & Gault
Monitoring of Patient Weight


Toxicity Prevention and Management

* NEW * Management of Immunotherapy-related adverse events

Anti-emetics
Diarrhoea
Extravasation
G-CSF guidelines
Hepatitis B testing pathway
Hypomagnesaemia
Mucositis and Mouthcare
Good Mouth care Patient Information Leaflet
PPE
Tumour Lysis Syndrome – prevention and treatment

Denosumab
Zoledronic acid

CMV management


Guidelines associated with Infusion-related Reactions

Administration Guidelines for cytotoxics associated with infusion-related reactions
Management of Allergic Reactions and Anaphylaxis
Carboplatin Hypersensitivity Guidelines and Desensitising Regimen
Oxaliplatin Hypersensitivity and Desensitising Regimen


Immunisation guidance for chemotherapy patients

Immunisation guidance for chemotherapy patients

Immunisation guidance – letter to GPs


Non-oncology section

Cyclophosphamide IV for non-oncology use
Cyclophosphamide IV consent form
Pathway for referring non-oncology patients for IV cyclophosphamide